These cold tumors exhibit lower density and distribution of CD8+ T cells, lower B7/PD-L1 expression, and decreased major histocompatibility complex (MHC) class I expression on tumor cells, resulting in a diminished immune response. The gene discussed is CD8A; the disease is neoplasm.